FAK
FAK (focal adhesion kinase), also known as PTK2, is a focal adhesion-associated protein kinase involved in cellular adhesion and spreading processes.
Products Related to FAK(45)
- GC64377Batatasin IIICAS: 56684-87-8Purity: >99.00%
Batatasin III, a stilbenoid, inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition (EMT) and FAK-AKT signals. Batatasin III has anti-cancer activities.
- GC64888GSK215CAS: 2743427-26-9Purity: >99.00%
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader with a pDC50 of 8.4. GSK215 is designed by a binder for the VHL E3 ligase and the FAK inhibitor VS-4718. GSK215 induces rapid and prolonged FAK degradation, giving a long-lasting effect on FAK levels and a marked pharmacokinetic/pharmacodynamics (PK/PD) disconnect.
- GC64992YH-306CAS: 1373764-75-0Purity: >98.00%
YH-306 is an antitumor agent. YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway. YH-306 significantly inhibits the migration and invasion of colorectal cancer cells. YH-306 potently suppresses uninhibited proliferation and induces cell apoptosis. YH-306 suppresses the activation of FAK, c-Src, paxillin, and PI3K, Rac1 and the expression of MMP2 and MMP9. YH-306 also inhibita actin-related protein (Arp2/3) complex-mediated actin polymerization.
- GC65457BI-3663CAS: 2341740-84-7Purity: >99.00%
BI-3663 is a highly selective PTK2/FAK PROTAC (DC50=30 nM), with Cereblon ligands to hijack E3 ligases for PTK2 degradation. BI-3663 inhibits PTK2 with an IC50 of 18 nM. BI-3663 is a PROTAC that composes of BI-4464 linked to Pomalidomide with a linker. Anti-cancer activity.
- GC68626AdhesamineCAS: 462605-73-8Purity: >95.00%
Adhesamine is a dumbbell-shaped molecule that can activate the MAPK/FAK pathway. Adhesamine promotes adhesion and growth of mammalian cells. Adhesamine accelerates differentiation of primary cultured mouse hippocampal neurons and improves survival rate.
- GC72932Adhesamine diTFACAS: 1201698-09-0
Adhesamine diTFA is a dumbbell-shaped molecule that activates the MAPK/FAK pathway.
- GC73149FLT3-IN-17CAS: 2758999-62-9Purity: >99.00%
FLT3-IN-17 inhibits CYPs and FLT3 mutants activity (IC50s: <0.5 nM for D835Y).
- GC73424PRT062607 acetateCAS: 1370261-98-5Purity: >99.00%
PRT062607 (P505-15) acetate is an orally available Syk inhibitor (IC50: 1 nM) that inhibits inflammation and induction Apoptosis.
- GC79141T7 Peptide TFAPurity: >98.00%
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor.
- GC79423IL13Rα2 D1CAS: 2319573-67-4Purity: >99.00%
IL13Rα2 D1 is an effective IL-13/IL13Rα2 signaling axis inhibitor.
- GC81301BSJ-04-146CAS: 2414478-45-6Purity: >98%
BSJ-04-146 is a highly efficient and selective PROTAC targeting focal adhesion kinase ( FAK ) inhibitor( IC 50 = 26 nM).
- GC81313STARD3-IN-1CAS: 1424357-72-1Purity: >99.00%
STARD3-IN-1 (Compound VS1) is a STARD3 inhibitor with an IC₅₀ of 35 μM.
- GC81556FZ1 peptidePurity: >99.50%
FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC64015 | AMP-945 | 1393653-34-3 | >98.00% | |
AMP-945 is an inhibitor of the enzyme focal adhesion kinase (FAK). | ||||
| GC64377 | Batatasin III | 56684-87-8 | >99.00% | |
Batatasin III, a stilbenoid, inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition (EMT) and FAK-AKT signals. Batatasin III has anti-cancer activities. | ||||
| GC64888 | GSK215 | 2743427-26-9 | >99.00% | |
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader with a pDC50 of 8.4. GSK215 is designed by a binder for the VHL E3 ligase and the FAK inhibitor VS-4718. GSK215 induces rapid and prolonged FAK degradation, giving a long-lasting effect on FAK levels and a marked pharmacokinetic/pharmacodynamics (PK/PD) disconnect. | ||||
| GC64992 | YH-306 | 1373764-75-0 | >98.00% | |
YH-306 is an antitumor agent. YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway. YH-306 significantly inhibits the migration and invasion of colorectal cancer cells. YH-306 potently suppresses uninhibited proliferation and induces cell apoptosis. YH-306 suppresses the activation of FAK, c-Src, paxillin, and PI3K, Rac1 and the expression of MMP2 and MMP9. YH-306 also inhibita actin-related protein (Arp2/3) complex-mediated actin polymerization. | ||||
| GC65457 | BI-3663 | 2341740-84-7 | >99.00% | |
BI-3663 is a highly selective PTK2/FAK PROTAC (DC50=30 nM), with Cereblon ligands to hijack E3 ligases for PTK2 degradation. BI-3663 inhibits PTK2 with an IC50 of 18 nM. BI-3663 is a PROTAC that composes of BI-4464 linked to Pomalidomide with a linker. Anti-cancer activity. | ||||
| GC65886 | BI-853520 | 1227948-82-4 | >98% | |
BI 853520 (IN-10018) is an orally active and potent focal adhesion kinase (FAK) inhibitor (recombinant FAK IC50=1nM). BI 853520 shows anti-proliferative activity against cancer cells. | ||||
| GC68030 | FAK-IN-7 | 19948-85-7 | >98% | |
| GC68463 | ULK1-IN-2 | 2497409-01-3 | >98% | |
| GC68626 | Adhesamine | 462605-73-8 | >95.00% | |
Adhesamine is a dumbbell-shaped molecule that can activate the MAPK/FAK pathway. Adhesamine promotes adhesion and growth of mammalian cells. Adhesamine accelerates differentiation of primary cultured mouse hippocampal neurons and improves survival rate. | ||||
| GC72932 | Adhesamine diTFA | 1201698-09-0 | - | |
Adhesamine diTFA is a dumbbell-shaped molecule that activates the MAPK/FAK pathway. | ||||
| GC73041 | ZINC40099027 | 1211825-25-0 | >98.00% | |
ZINC40099027 is a FAK activator. | ||||
| GC73149 | FLT3-IN-17 | 2758999-62-9 | >99.00% | |
FLT3-IN-17 inhibits CYPs and FLT3 mutants activity (IC50s: <0.5 nM for D835Y). | ||||
| GC73424 | PRT062607 acetate | 1370261-98-5 | >99.00% | |
PRT062607 (P505-15) acetate is an orally available Syk inhibitor (IC50: 1 nM) that inhibits inflammation and induction Apoptosis. | ||||
| GC73575 | FAK-IN-14 | 2766666-22-0 | >99.00% | |
FAK-IN-14 (compound 8d) is a focal adhesion kinase(FAK) inhibitor with an IC50 value of 0.2438 nM. | ||||
| GC74116 | Pyk2-IN-2 | 1271418-15-5 | >98.00% | |
Pyk2-IN-2 (compound 13j) is an inhibitor of Pyk2 with an IC50 of FAK kinase of 0.608 μM. | ||||
| GC79141 | T7 Peptide TFA | - | >98.00% | |
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor. | ||||
| GC79423 | IL13Rα2 D1 | 2319573-67-4 | >99.00% | |
IL13Rα2 D1 is an effective IL-13/IL13Rα2 signaling axis inhibitor. | ||||
| GC81301 | BSJ-04-146 | 2414478-45-6 | >98% | |
BSJ-04-146 is a highly efficient and selective PROTAC targeting focal adhesion kinase ( FAK ) inhibitor( IC 50 = 26 nM). | ||||
| GC81313 | STARD3-IN-1 | 1424357-72-1 | >99.00% | |
STARD3-IN-1 (Compound VS1) is a STARD3 inhibitor with an IC₅₀ of 35 μM. | ||||
| GC81328 | GZD-552 | - | >98% | |
GZD-552 is a potent orally active FAK inhibitor with a human FAK IC 50 of 5.8 nM. | ||||
| GC81556 | FZ1 peptide | - | >99.50% | |
FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist. | ||||
